FDA Clearance Tracker · K232999
Lyric4 Hearing Aid
Last checked: Nov 19, 2026Latest source record: Apr 11, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Apr 11, 2024
Substantially Equivalent
Time to decision
202 days
Received Sep 22, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K232999
- Device name
- Lyric4 Hearing Aid
- Applicant
- Sonova AG
- Applicant location
- Staefa, CH
- Received
- Sep 22, 2023
- Decided
- Apr 11, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class I
- Regulation
- 21 CFR 874.3300
- Specialty
- Otolaryngology (ENT)
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code ESD. The earliest in FDA's data is K760215, decided Jul 21, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K232999
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Sonova AG
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K230538 · Decided Jun 16, 2023 · 109 days after receipt
Device type: Self-Fitting Air-Conduction Hearing Aid, Over The Counter (QUH) · Otolaryngology (ENT)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.